Cargando…
Low expression of CD200 predicts shorter time-to-treatment in chronic lymphocytic leukemia
CD200, formerly known as OX-2, is a type I glycoprotein that is expressed on a variety of cell types. CD200 has been shown to be overexpressed in chronic lymphocytic leukemia (CLL). Although previous studies have confirmed the diagnostic value of CD200 in differentiating CLL from to other B-cell chr...
Autores principales: | Miao, Yi, Fan, Lei, Wu, Yu-Jie, Xia, Yi, Qiao, Chun, Wang, Yan, Wang, Li, Hong, Min, Zhu, Hua-Yuan, Xu, Wei, Li, Jian-Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924660/ https://www.ncbi.nlm.nih.gov/pubmed/26910908 http://dx.doi.org/10.18632/oncotarget.6948 |
Ejemplares similares
-
Low prevalence and independent prognostic role of del(11q) in Chinese patients with chronic lymphocytic leukemia
por: Zou, Yi-Xin, et al.
Publicado: (2021) -
CD200 and Chronic Lymphocytic Leukemia: Biological and Clinical Relevance
por: D’Arena, Giovanni, et al.
Publicado: (2020) -
MYD88 mutations predict unfavorable prognosis in Chronic Lymphocytic Leukemia patients with mutated IGHV gene
por: Qin, Shu-Chao, et al.
Publicado: (2017) -
Prognostic Value of Serum CD200 Concentrations in Chronic Lymphocytic Leukemia
por: Aref, Salah, et al.
Publicado: (2023) -
CD200 Baseline Serum Levels Predict Prognosis of Chronic Lymphocytic Leukemia
por: D’Arena, Giovanni, et al.
Publicado: (2021)